envafolimab: Clinical Trials

3 trials of envafolimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow envafolimab: new trials by email Literature Review of envafolimab trials Research Report on envafolimab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
Cetuxima-β, Envafolimab, mFOLFOX6 - Metastatic Colorectal Cancer (CRC)
Phase 2 / Phase 3Not yet recruitingSun Yat-sen University5902025-06-012025-05-06
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
Envafolimab - Rectal Cancer
Phase 3RecruitingSir Run Run Shaw Hospital1082023-04-012026-09-24
Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
KN035 plus Gemcitabine & oxaliplatin, Gemcitabine & oxaliplatin - Biliary Tract Neoplasms
Phase 3Completed3D Medicines (Sichuan) Co., Ltd.4722018-04-162026-09-23

Conditions studied

Biliary Tract Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

3D Medicines (Sichuan) Co., Ltd. (1)  ·  Sir Run Run Shaw Hospital (1)  ·  Sun Yat-sen University (1)

Countries

China (3)

Top investigators

Shukui Qin (1)